Gore & Associates, Inc Medtronic and St Jude and has research grants from Cook Medical, Edwards Lifesciences, and St Jude Medical. is a consultant for Thrasos Therapeutics. has received consulting fees from Medtronic, Terumo, and W.L. was generously supported by the David Hamilton Fund and the Phil Jenkins Breakthrough Fund in Cardiac Surgery at the University of Michigan Frankel Cardiovascular Center.ĭr H.J.P. Gore & Associates, Inc Medtronic the Varbedian Aortic Research Fund, the Hewlett Foundation the Mardigian Foundation UM Faculty Group Practice Terumo and Ann and Bob Aikens.
Hemiarch replacement was utilized more frequently (T1: 27.0%, T2: 63.3%, and T3: 51.7% trend P = .001) and partial arch was utilized less frequently (T1: 20.7%, T2: 12.0%, and T3: 8.4% trend P < .001), whereas complete arch replacement was used similarly ( P = .131).
Arterial perfusion through axillary cannulation increased (T1: 18.0%, T2: 33.2%, and T3: 55.7%), whereas perfusion via a femoral approach diminished (T1: 76.0%, T2: 53.3%, and T3: 30.1%) (both P values < .001). Biologic valves were increasingly utilized (T1: 35.6%, T2 40.6%, and T3: 52.0% trend P = .009), whereas mechanical valve use decreased (T1: 57.6%, T2: 58.0%, and T3: 45.4% trend P = .027) for aortic valve replacement.
0 kommentar(er)
